[xoo_el_inline_form active="login"]

Pipeline

Line

Armed-T Product Pipeline

CytoArm owns >50 Armed T product rights for cancers and autoimmune diseases
Pipeline
1st Product: Armed T cell (CTA-02) for EGFR mutated colorectal cancer